news.header.description
Thailand’s medical and wellness tourism platform, ArokaGO (www.arokago.com), was honored to be a representative from Thailand on the main stage at the 2025 Global Industrial Internet Conference (GIIC), held in Shenyang, Liaoning Province, People’s Republic of China, from September 5–8, 2025.
news.actions.readNewsThe Faculty of Medicine Ramathibodi Hospital, Mahidol University, in collaboration with Samitivej Hospital Group, organized the “Cell Therapy & Gene Therapy Symposium 2025” from September 5–7, 2025, at Samitivej Srinakarin Hospital and Mövenpick BDMS Wellness Resort, Bangkok.
news.actions.readNewsThe Food and Drug Administration (FDA) has issued a warning after testing a cosmetic product, Praithong Organic Henna Powder, sampled from Bangkok Port. The tested lot (Lot No. 2408-05, MFD. 08/2024, EXP. 08/2027) was analyzed on October 18, 2024, by the Department of Medical Sciences. Results showed microbial contamination exceeding the legal safety standard.
news.actions.readNewsThe Tourism Authority of Thailand (TAT), in collaboration with Thai embassies, public and private sector partners, is driving forward international promotion of Thai tourism through “Thai Festival 2025” and marketing activities across Europe, America, and Asia. The initiative highlights Thai culture, cuisine, and wellness tourism while celebrating key diplomatic milestones. The goal is to expand the base of quality tourists and boost arrivals to Thailand during the high season to exceed set targets.
news.actions.readNewsThe Department of Disease Control (DDC) has reported five new cases of Mpox (monkeypox) in Thailand, while reassuring the public that the disease is treatable and generally not severe. Authorities emphasized the importance of prevention through avoiding close contact with infected individuals.
news.actions.readNewsFrom September 1, 2025, the European Union will officially ban cosmetic products containing Trimethylbenzoyl Diphenylphosphine Oxide (TPO), a chemical widely used in gel nail polishes. The substance is classified as “CMR 1B,” meaning it is suspected of causing cancer, genetic mutations, and reproductive harm. Under EU cosmetics law, such substances are not permitted.
news.actions.readNews